Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Enhanced Quadrivalent Vaccine Against Seasonal Influenza For The 2024-2025 Season

Folkehelseinstituttet Norway has Released a tender for Enhanced Quadrivalent Vaccine Against Seasonal Influenza For The 2024-2025 Season in Pharmaceuticals. The tender was released on Dec 20, 2023.

Country - Norway

Summary - Enhanced Quadrivalent Vaccine Against Seasonal Influenza For The 2024-2025 Season

Deadline - login to view

GT reference number - 76134970

Product classification - Influenza vaccines

Organization Details:

  Address - Norway

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 76134970

  Document Type - Tender Notices

Notice Details and Documents:

Description - The Norwegian Institute of Public Health (NIPH) is carrying out procurement of an enhanced quadrivalent vaccine against seasonal influenza for vaccination of particularly vulnerable people aged 65 or older (nursing home residents, extensive use of ho me nursing services etc). Enhanced influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups included in the national immunisation scheme. The procurement is governed by the provisions in parts I and III of the Norwegian Regulations relating to public procurement (Forskrift om offentlige anskaffelser, FOA).From 01.01.2024 the Ministry of Health and Care Services has decided th

Gt Ref Id - 76134970

Deadline - Feb 01, 2024

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database